Robinson Chandler
Insider CIK 1727334 · NONE Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | F Tax w/h | 2026-10-20 | 2026-10-20 | 597 | $92.59 | $55.3K | 104,127 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-09-30 | 2026-10-02 | 9,801 | — | $0 | 83,602 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-09-30 | 2026-10-02 | 4,344 | $79.67 | $346.1K | 104,724 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-09-30 | 2026-10-02 | 9,801 | — | — | 109,068 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-09-24 | 2026-09-28 | 14,056 | — | $0 | 15,044 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-09-24 | 2026-09-28 | 15,000 | — | $0 | 27,204 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-09-24 | 2026-09-28 | 15,000 | $14.00 | $210.0K | 128,323 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-09-24 | 2026-09-28 | 14,056 | $30.00 | $421.7K | 113,323 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 10,450 | $87.15 | $910.7K | 117,873 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 9,638 | $87.96 | $847.8K | 108,235 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 8,368 | $88.97 | $744.5K | 99,867 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 600 | $89.79 | $53.9K | 99,267 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-09-24 | 2026-09-28 | 15,000 | — | $0 | 27,204 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-09-24 | 2026-09-28 | 14,056 | — | $0 | 15,044 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 600 | $89.79 | $53.9K | 99,267 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 8,368 | $88.97 | $744.5K | 99,867 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 9,638 | $87.96 | $847.8K | 108,235 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-09-24 | 2026-09-28 | 10,450 | $87.15 | $910.7K | 117,873 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-09-24 | 2026-09-28 | 15,000 | $14.00 | $210.0K | 128,323 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-09-24 | 2026-09-28 | 14,056 | $30.00 | $421.7K | 113,323 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-06-30 | 2026-07-02 | 12,873 | — | $0 | 93,403 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-06-30 | 2026-07-02 | 4,084 | $92.59 | $378.1K | 99,267 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-06-30 | 2026-07-02 | 12,873 | — | $0 | 103,351 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-03-31 | 2026-04-02 | 6,732 | — | $0 | 106,276 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-03-31 | 2026-04-02 | 6,732 | — | $0 | 92,450 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2026-03-31 | 2026-04-02 | 1,972 | $54.79 | $108.0K | 90,478 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-12-31 | 2026-01-05 | 8,724 | — | $0 | 113,008 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-12-31 | 2026-01-05 | 2,558 | $65.30 | $167.0K | 85,718 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-12-31 | 2026-01-05 | 8,724 | — | $0 | 88,276 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 49,133 | — | $0 | 121,732 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 16,753 | — | $0 | 16,753 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-09-30 | 2025-10-02 | 8,726 | — | $0 | 72,599 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-09-30 | 2025-10-02 | 2,646 | $81.67 | $216.1K | 79,552 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-09-30 | 2025-10-02 | 8,726 | — | $0 | 82,198 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-09-24 | 2025-09-26 | 550,229 | $63.61 | $35.00M | 272,026 | SEC↗ |
| MNPR Monopar Therapeutics | X Exercise deriv | 2025-07-14 | 2025-07-16 | 16,800 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-07-14 | 2025-07-16 | 16,800 | $40.00 | $672.0K | 73,472 | SEC↗ |
| MNPR Monopar Therapeutics | X Exercise | 2025-07-14 | 2025-07-16 | 16,800 | $0.01 | $168 | 90,272 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-06-30 | 2025-07-02 | 13,344 | — | $0 | 81,325 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-06-30 | 2025-07-02 | 5,865 | $35.78 | $209.8K | 73,472 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-06-30 | 2025-07-02 | 13,344 | — | $0 | 79,337 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-04-02 | 2025-04-04 | 33,334 | $35.00 | $1.17M | 822,255 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-03-31 | 2025-04-02 | 4,106 | — | $0 | 94,669 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-03-31 | 2025-04-02 | 1,204 | $36.41 | $43.8K | 65,993 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-03-31 | 2025-04-02 | 4,106 | — | $0 | 67,197 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-03-04 | 2025-03-07 | 85,759 | — | $0 | 85,759 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2025-03-04 | 2025-03-07 | 6,002 | — | $0 | 98,775 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-03-04 | 2025-03-07 | 79,899 | — | $0 | 104,777 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2025-03-04 | 2025-03-07 | 1,759 | $31.70 | $55.8K | 63,091 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2025-03-04 | 2025-03-07 | 6,002 | — | $0 | 64,850 | SEC↗ |
| MNPR Monopar Therapeutics | J Other | 2025-01-28 | 2026-01-30 | 62,815 | — | $0 | 62,815 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-12-31 | 2025-01-02 | 4,895 | — | $0 | 24,879 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-12-31 | 2025-01-02 | 2,209 | $22.00 | $48.6K | 58,848 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-12-31 | 2025-01-02 | 4,895 | — | $0 | 61,057 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-09-30 | 2024-10-02 | 4,895 | — | $0 | 29,774 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-09-30 | 2024-10-02 | 4,895 | — | $0 | 58,080 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-09-30 | 2024-10-02 | 1,918 | $6.74 | $12.9K | 56,162 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-06-30 | 2024-07-02 | 24,476 | — | $0 | 173,335 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-06-30 | 2024-07-02 | 24,476 | — | $0 | 274,607 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-06-30 | 2024-07-02 | 8,684 | $0.73 | $6.3K | 265,923 | SEC↗ |
| MNPR Monopar Therapeutics | X Exercise deriv | 2024-05-28 | 2024-05-30 | 84,000 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | X Exercise | 2024-05-28 | 2024-05-30 | 84,000 | — | $0 | 250,131 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-03-31 | 2024-04-02 | 24,474 | — | $0 | 197,811 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-03-31 | 2024-04-02 | 24,474 | — | $0 | 173,303 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-03-31 | 2024-04-02 | 7,172 | $0.68 | $4.9K | 166,131 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-01-01 | 2024-01-03 | 6,724 | — | $0 | 222,285 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-01-01 | 2024-01-03 | 2,327 | $0.34 | $791 | 148,829 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-01-01 | 2024-01-03 | 6,724 | — | $0 | 151,156 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-12-31 | 2024-01-03 | 24,474 | — | $0 | 229,009 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-12-31 | 2024-01-03 | 24,474 | — | $0 | 152,901 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-12-31 | 2024-01-03 | 8,469 | $0.34 | $2.9K | 144,432 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-09-30 | 2023-10-03 | 24,474 | — | $0 | 253,483 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-09-30 | 2023-10-03 | 24,474 | — | $0 | 135,599 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-09-30 | 2023-10-03 | 7,172 | $0.62 | $4.4K | 128,427 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-06-30 | 2023-07-03 | 35,039 | — | $0 | 277,957 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-06-30 | 2023-07-03 | 35,039 | — | $0 | 121,394 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-06-30 | 2023-07-03 | 10,269 | $0.86 | $8.8K | 111,125 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-03-31 | 2023-04-04 | 13,911 | — | $0 | 312,996 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-03-31 | 2023-04-04 | 4,286 | $1.39 | $6.0K | 86,355 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-03-31 | 2023-04-04 | 13,911 | — | $0 | 90,641 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 169,012 | — | $0 | 326,907 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 221,839 | — | $0 | 221,839 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-01-01 | 2023-01-03 | 6,723 | — | $0 | 6,724 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-01-01 | 2023-01-03 | 2,327 | $2.37 | $5.5K | 76,730 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-01-01 | 2023-01-03 | 6,723 | — | $0 | 79,057 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-12-31 | 2023-01-03 | 13,912 | — | $0 | 151,171 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-12-31 | 2023-01-03 | 13,912 | — | $0 | 77,148 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-12-31 | 2023-01-03 | 4,814 | $2.37 | $11.4K | 72,334 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-09-30 | 2022-10-03 | 13,911 | — | $0 | 178,530 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-09-30 | 2022-10-03 | 4,077 | $1.52 | $6.2K | 63,236 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-09-30 | 2022-10-03 | 13,911 | — | $0 | 67,313 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-06-30 | 2022-07-01 | 23,882 | — | $0 | 192,441 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-06-30 | 2022-07-01 | 6,999 | $2.30 | $16.1K | 53,402 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-06-30 | 2022-07-01 | 23,882 | — | $0 | 60,401 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-03-31 | 2022-04-01 | 3,941 | — | $0 | 216,323 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-03-31 | 2022-04-01 | 1,155 | $2.55 | $2.9K | 36,519 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-03-31 | 2022-04-01 | 3,941 | — | $0 | 37,674 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 211,018 | — | $0 | 211,018 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 159,522 | — | $0 | 220,264 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-01-01 | 2022-01-04 | 6,724 | — | $0 | 13,447 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-01-01 | 2022-01-04 | 6,724 | — | $0 | 36,060 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-01-01 | 2022-01-04 | 2,327 | $3.21 | $7.5K | 33,733 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-12-31 | 2022-01-04 | 3,941 | — | $0 | 47,295 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-12-31 | 2022-01-04 | 1,364 | $3.21 | $4.4K | 29,336 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-12-31 | 2022-01-04 | 3,941 | — | $0 | 30,700 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-09-30 | 2021-10-01 | 3,941 | — | $0 | 51,236 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-09-30 | 2021-10-01 | 3,941 | — | $0 | 27,914 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-09-30 | 2021-10-01 | 1,155 | $4.87 | $5.6K | 26,759 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-06-30 | 2021-07-02 | 7,883 | — | $0 | 55,177 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-06-30 | 2021-07-02 | 7,883 | — | $0 | 26,283 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-06-30 | 2021-07-02 | 2,310 | $5.89 | $13.6K | 23,973 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 16,384 | $16.44 | $269.4K | 178,596 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 29,996 | $15.12 | $453.5K | 194,980 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 42,467 | $13.30 | $564.8K | 249,200 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 11,929 | $16.90 | $201.6K | 166,667 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2021-02-11 | 2021-02-16 | 24,224 | $14.09 | $341.3K | 224,976 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 70,000 | — | $0 | 70,000 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 63,060 | — | $0 | 83,231 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-01-01 | 2021-01-05 | 6,724 | — | $0 | 20,171 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-01-01 | 2021-01-05 | 6,724 | — | $0 | 20,727 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-01-01 | 2021-01-05 | 2,327 | $6.12 | $14.2K | 18,400 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 26,895 | — | $0 | 26,895 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 111,753 | — | $0 | 111,753 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2019-12-18 | 2019-12-20 | 125,000 | $8.00 | $1.00M | 291,667 | SEC↗ |
| NONE Monopar Therapeutics | A Award deriv | 2018-08-09 | 2018-09-27 | 145,500 | — | $0 | 145,500 | SEC↗ |